The glucagon pathway in particular produces effects, including thermogenesis and hepatic lipid mobilization, that no prior GLP-1 or GLP-1/GIP compound prepared the body for
Wegovy single-dose pens do not have a click-counting mechanism
Considering obesity is a chronic medical condition, there should be an expectation that it will require lifelong treatmentmuch like diabetes, hypertension or any other chronic illness
Because of their glucose lowering effects, therapies that enhance incretin actions through inhibiting degradation of endogenous incretins or through activation of the GLP-1 receptor are now in use for the treatment of type 2 diabetes ( ATP channels and in postprandial hypoglycemia after gastrointestinal surgery, where the delivery of nutrients to the small intestine is altered resulting in both hyperglycemia and an exaggerated secretion of GLP-1
I would love to hear about a medicine like Ozempic being an adjunctive to that conversation, not the center of that conversation, he said
